Skip to main content

06-23-2017 | Hyperglycemia | Review | Article

Management of Hyperglycemia and Diabetes in the Emergency Department

Journal: Current Diabetes Reports

Authors: Justin B. Echouffo-Tcheugui, Rajesh Garg

Publisher: Springer US


Purpose of Review

Hyperglycemia in the emergency department (ED) is being recognized as a public health problem and presents a clinical challenge. This review critically summarizes available evidence on the burden, etiology, diagnosis, and practical management strategies for hyperglycemia in the ED.

Recent Findings

Diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar state (HHS) are hyperglycemic emergencies that commonly present to the ED. However, the most common form of hyperglycemia in ED is associated with non-hyperglycemic medical emergencies. The presence of hyperglycemia increases the mortality and morbidity associated with the primary condition. The related hospital admission rates and costs are also elevated. The frequency of DKA or HHS related mortality and morbidity has remained high over the last decade. However, attempts have been made to improve management of all hyperglycemia in the ED. Evidence suggests that better management of hyperglycemia in the ED with proper follow-up improves clinical outcomes and prevents readmission.


Optimization of the hyperglycemia management in the ED may improve clinical outcomes. However, more clinical trial data on the outcomes and cost-effectiveness of various management strategies or protocols are needed.
Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and trends in diabetes among adults in the United States, 1988-2012. JAMA. 2015;314:1021–9. CrossRefPubMed
Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes care. 2009;32:1335–43. CrossRefPubMedPubMedCentral
Martin WG, Galligan J, Simpson S, Greenaway T, Burgess J. Admission blood glucose predicts mortality and length of stay in patients admitted through the emergency department. Intern Med J. 2015;45:916–24. CrossRefPubMed
Zelihic E, Poneleit B, Siegmund T, Haller B, Sayk F, Dodt C. Hyperglycemia in emergency patients–prevalence and consequences: results of the GLUCEMERGE analysis. Eur J Emerg Med [Internet]. 2015;22:181–7. CrossRef
Centers for Disease Control. Number of Emergency Department Visits with Diabetes as Any-Listed Diagnosis, All Ages, United States, 2006–2009 [Internet]. [cited 2017 Jan 5] Available from: https://​www.​cdc.​gov/​diabetes/​statistics/​emergency/​fig1.​htm
Ozieh MN, Bishu KG, Dismuke CE, Egede LE. Trends in health care expenditure in U.S. adults with diabetes: 2002-2011. Diabetes Care. 2015;38:1844–51. CrossRefPubMedPubMedCentral
• Wang J, Geiss LS, Williams DE, Gregg EW. Trends in emergency department visit rates for hypoglycemia and hyperglycemic crisis among adults with diabetes, United States, 2006-2011. PLoS one. 2015;10. This study estimated the number of ED visits for hypoglycemia and hyperglycemic crisis among adults with diabetes during the period of 2006 to 2011, while ED visit rates for hypoglycemia declined, ED visit rates for hyperglycemic crisis did not change
Lipska KJ, Ross JS, Wang Y, Inzucchi SE, Minges K, Karter AJ, et al. National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011. JAMA Intern Med. 2014;174:1116–24. CrossRefPubMedPubMedCentral
Ginde AA, Delaney KE, Lieberman RM, Vanderweil SG, Camargo CA. Estimated risk for undiagnosed diabetes in the emergency department: a multicenter survey. Acad Emerg Med. 2007;14:492–5. CrossRefPubMed
Ginde AA, Cagliero E, Nathan DM, Camargo CA. Value of risk stratification to increase the predictive validity of HbA1c in screening for undiagnosed diabetes in the US population. J Gen Intern Med. 2008;23:1346–53. CrossRefPubMedPubMedCentral
Charfen MA, Ipp E, Kaji AH, Saleh T, Qazi MF, Lewis RJ. Detection of undiagnosed diabetes and prediabetic states in high-risk emergency department patients. Acad Emerg Med. 2009;16:394–402. CrossRefPubMed
Association AD. Standards of Medical Care in Diabetes—2016: classification and diagnosis of diabetes. Diabetes Care. 2016;39:S13–22. l. CrossRef
Silverman RA, Thakker U, Ellman T, Wong I, Smith K, Ito K, et al. Hemoglobin A1c as a screen for previously undiagnosed prediabetes and diabetes in an acute-care setting. Diabetes care. 2011;34:1908–12. CrossRefPubMedPubMedCentral
Charfen MA, Ipp E, Kaji AH, Saleh T, Qazi MF, Lewis RJ. Detection of undiagnosed diabetes and prediabetic states in high-risk emergency department patients. Acad Emerg Med. 2009;16:394–402. CrossRefPubMed
Ginde AA, Savaser DJ, Camargo CA. Limited communication and management of emergency department hyperglycemia in hospitalized patients. J Hosp Med. 2009;4:45–9. CrossRefPubMed
Alberti KG. Role of glucagon and other hormones in development of diabetic ketoacidosis. The Lancet (London, England). 1975;1:1307–11.
Schade DS, Eaton RP. The temporal relationship between endogenously secreted stress hormones and metabolic decompensation in diabetic man. J Clin Endocrinol Metab. 1980;50:131–6. CrossRefPubMed
McGarry JD, Dobbins RL. Fatty acids, lipotoxicity and insulin secretion. Diabetologia. 1999;42:128–38. CrossRefPubMed
Lévy-Marchal C, Patterson CC, Green A. Geographical variation of presentation at diagnosis of type I diabetes in children: the EURODIAB study. Diabetologia. 2001;44:B75–80. CrossRefPubMed
Kitabchi AE, Umpierrez GE, Murphy MB, Barrett EJ, Kreisberg RA, Malone JI, et al. Management of hyperglycemic crises in patients with diabetes. Diabetes care. 2001;24:131–53. CrossRefPubMed
Ennis ED, Stahl v EJB, Kreisberg RA. The hyperosmolar hyperglycemic syndrome. Diabetes Rev. 1994;2:115–26.
Wachtel TJ, Silliman RA, Lamberton P. Predisposing factors for the diabetic hyperosmolar state. Arch Intern Med [Internet]. 1987;147:499–501. CrossRef
Pozzilli P, Battelino T, Danne T, Hovorka R, Jarosz-Chobot P, Renard E. Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics. Diabetes Metab Res Rev. 2016;32(1):21–39. CrossRefPubMed
Usher-Smith JA, Thompson MJ, Sharp SJ, Walter FM. Factors associated with the presence of diabetic ketoacidosis at diagnosis of diabetes in children and young adults: a systematic review. BMJ. 2011;343:d4092. CrossRefPubMedPubMedCentral
Warner EA, Greene GS, Buchsbaum MS, Cooper DS, Robinson BE. Diabetic ketoacidosis associated with cocaine use. Arch. Intern. Med. 1998;158:1799–802. CrossRefPubMed
Yoshida N, Goto H, Suzuki H, Nagasawa K, Takeshita A, Okubo M, et al. Ketoacidosis as the initial clinical condition in nine patients with acromegaly: a review of 860 cases at a single institute. Eur J Endocrinol. 2013;169:127–32. CrossRefPubMed
Umpierrez GE, Latif K, Stoever J, Cuervo R, Park L, Freire AX, et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. Am J Med. 2004;117:291–6. CrossRefPubMed
Kitabchi AE, Umpierrez GE, Fisher JN, Murphy MB, Stentz FB. Thirty years of personal experience in hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state. J Clin Endocrinol Metab. 2008;93:1541–52. CrossRefPubMedPubMedCentral
Luzi L, Barrett EJ, Groop LC, Ferrannini E, DeFronzo RA. Metabolic effects of low-dose insulin therapy on glucose metabolism in diabetic ketoacidosis. Diabetes. 1988;37:1470–7. CrossRefPubMed
Goyal N, Miller JB, Sankey SS, Mossallam U. Utility of initial bolus insulin in the treatment of diabetic ketoacidosis. J Emerg Med. 2010;38:422–7. CrossRefPubMed
Umpierrez GE, Kelly JP, Navarrete JE, Casals MM, Kitabchi AE. Hyperglycemic crises in urban blacks. Arch Intern Med. 1997;157:669–75. CrossRefPubMed
Umpierrez GE, Jones S, Smiley D, Mulligan P, Keyler T, Temponi A, et al. Insulin analogs versus human insulin in the treatment of patients with diabetic ketoacidosis: a randomized controlled trial. Diabetes Care. 2009;32:1164–9. CrossRefPubMedPubMedCentral
Adrogué HJ, Lederer ED, Suki WN, Eknoyan G. Determinants of plasma potassium levels in diabetic ketoacidosis. Medicine (Baltimore). 1986;65:163–72. CrossRef
Beigelman PM. Potassium in severe diabetic ketoacidosis. Am J Med. 1973;54:419–20. CrossRefPubMed
Chua HR, Schneider A, Bellomo R. Bicarbonate in diabetic ketoacidosis - a systematic review. Ann. Intensive Care. 2011;1:23. CrossRefPubMedPubMedCentral
Bureau MA, Bégin R, Berthiaume Y, Shapcott D, Khoury K, Gagnon N. Cerebral hypoxia from bicarbonate infusion in diabetic acidosis. J Pediatr. 1980;96:968–73. CrossRefPubMed
Wilson HK, Keuer SP, Lea AS, Boyd AE, Eknoyan G. Phosphate therapy in diabetic ketoacidosis. Arch. Intern Med. 1982;142:517–20. CrossRefPubMed
Fisher JN, Kitabchi AE. A randomized study of phosphate therapy in the treatment of diabetic ketoacidosis. J Clin Endocrinol Metab. 1983;57:177–80. CrossRefPubMed
Winter RJ, Harris CJ, Phillips LS, Green OC. Diabetic ketoacidosis. Induction of hypocalcemia and hypomagnesemia by phosphate therapy. Am. J Med. 1979;67:897–900. CrossRefPubMed
Watts W, Edge JA. How can cerebral edema during treatment of diabetic ketoacidosis be avoided? Pediatr Diabetes. 2014;15:271–6. CrossRefPubMed
Hsia E, Seggelke S, Gibbs J, Hawkins RM, Cohlmia E, Rasouli N, et al. Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia. J Clin Endocrinol Metab. 2012;97:3132–7. CrossRefPubMed
Charfen MA, Fernández-Frackelton M. Diabetic ketoacidosis. Emerg Med Clin North Am. 2005;23:609–28. vii CrossRefPubMed
Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes care. 2009;32:193–203. CrossRefPubMedPubMedCentral
Dubin J, Nassar C, Sharretts J, Youssef G, Curran J, Magee M. Step-DC: stop emergency department visits for hyperglycemia project -DC. Ann Emerg Med. 2009;54:S18. CrossRef
Munoz C, Villanueva G, Fogg L, Johnson T, Hannold K, Agruss J, et al. Impact of a subcutaneous insulin protocol in the emergency department: Rush Emergency Department Hyperglycemia Intervention (REDHI). J. Emerg. Med. 2011;40:493–8. 46 CrossRefPubMed
Bernard JB, Munoz C, Harper J, Muriello M, Rico E, Baldwin D. Treatment of inpatient hyperglycemia beginning in the emergency department: a randomized trial using insulins aspart and detemir compared with usual care. J Hosp Med. 2011;6:279–84. CrossRefPubMed
Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes care. 2009;32:1119–31. CrossRefPubMedPubMedCentral
Van den Berghe G, Wilmer A, Milants I, Wouters PJ, Bouckaert B, Bruyninckx F, et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes. 2006;55:3151–9. CrossRefPubMed
Umpierrez GE, Palacio A, Smiley D. Sliding scale insulin use: myth or insanity? Am J Med. 2007;120:563–7. CrossRefPubMed
Pasquel FJ, Gianchandani R, Rubin DJ, Dungan KM, Anzola I, Gomez PC, et al. Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial. The Lancet Diabetes Endocrinol. 2017;5(2):125–33. CrossRefPubMed
•• Palermo NE, Modzelewski KL, Farwell AP, Fosbroke J, Shankar KN, Alexanian SM, et al. Open access to diabetes center from the emergency department reduces hospitalizations in the susequent year. Endocr. Pract. 2016;22:1161–9. Providing an appointment for diabetes clinic in the ED and thus removing barriers to ambulatory care was associated with significant reductions in hospitalization rate, ED recidivism rate, HbA1c, and healthcare expenditures in the subsequent year CrossRefPubMed
• Magee MF, Nassar CM, Mete M, White K, Youssef GA, Dubin JS. The synergy to enable glycemic control following emergency department discharge program for adults with type 2 diabetes: step-diabetes. Endocr. Pract. 2015;21:1227–39. Diabetes self-management education was provided to ED patients with blood glucose (BG) levels ≥200 mg/dL. This focused approach led to improvement in short-term glycemic outcomes and medication adherence. CrossRefPubMed
Chung N, Rascati K, Lopez D, Jokerst J, Garza A. Impact of a clinical pharmacy program on changes in hemoglobin A1c, diabetes-related hospitalizations, and diabetes-related emergency department visits for patients with diabetes in an underserved population. J Manag care Spec Pharm. 2014;20:914–9. PubMed
Magee MF, Nassar CM, Copeland J, Fokar A, Sharretts JM, Dubin JS, et al. Synergy to reduce emergency department visits for uncontrolled hyperglycemia. Diabetes Educ. 2013;39:354–64. CrossRefPubMed